The Rise Of The pCPA Heralds More Pricing Pressure In Canada
This article was originally published in Scrip
Executive Summary
It looks as though there could be yet more pricing pressure on companies selling drugs in Canada after the country's federal government said it would be joining the pan-Canadian Pharmaceutical Alliance, the body that negotiates lower drugs prices for Canada's many publicly funded drug plans.